Skip to main content

Advertisement

Table 1 Participant demographics and baseline data from participants who completed the 12 month assessment

From: Cost-effectiveness of using a motion-sensor biofeedback treatment approach for the management of sub-acute or chronic low back pain: economic evaluation alongside a randomised trial

  Intervention Control
n 38 45
Age 39 (14) 49 (12)
Gender 18 (47%) female 26 (58%) female
Pain intensity (QVAS) (0–100 scale, mean) 61.4 (16.0) 61.0 (12.0)
Pain episode duration (weeks, median) 52 (IQR: 17.5, 62.5) 52 (IQR: 16, 364)
Fear of movement (Fear Avoidance Beliefs Questionnaire: Physical Activity subscale) (0–24 scale, mean) 14.4 (6.4) 14.2 (6.6)
Activity limitation (Patient Specific Functional Scale) (0–100 scale, mean) 3.9 (1.7) 4.4 (2.4)
Activity limitation (Roland-Morris Disability Questionnaire) (0–100 scale, mean) 52.6 (19.9) 45.6 (26.4)
$AUD medication use per day at baseline $1.03 ($0.91) $0.96 ($0.75)
$AUD weekly income estimate based on gender and industry codes $1467 ($265) $1433 ($301)
Employment industry codes
 Professional, Scientific and Technical services 10 (26%) 5 (11%)
 Health Care and Social Assistance 4 (11%) 10 (22%)
 Agricultural, Forestry and Fishing 4 (11%) 5 (11%)
 Administrative and Support services 4 (11%) 3 (7%)
 Education and Training 2 (5%) 5 (11%)
 Transport, Postal and Warehousing 2 (5%) 3 (7%)
 Other categories 12 (32%) 14 (31%)
  1. Data are mean (sd) or n (%) unless otherwise indicated